Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document discusses various nail and hair disorders and their treatments.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

The document provides detailed care instructions for elderly patients.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Understanding sex and gender differences can improve personalized dermatology care.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Managing multiple autoimmune diseases in one patient is very challenging.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

Immunoadsorption successfully treated a man's resistant polymyositis.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Pyoderma gangrenosum can occur in rheumatoid arthritis patients and may be mistaken for vasculitis.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

Pityriasis rubra pilaris can occur with myasthenia gravis.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

RHUPUS should be considered in children with deforming arthritis.